Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment

NCT00538291 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Study was terminated early due to lack of efficacy.

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: capecitabine
GENETIC: gene expression analysis
GENETIC: microarray analysis
GENETIC: polymorphism analysis
GENETIC: reverse transcriptase-polymerase chain reaction
OTHER: immunohistochemistry staining method

Sponsor

City of Hope Medical Center

Collaborators

[object Object]